Literature DB >> 29378845

Estrogen receptor α protects pancreatic β-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stress.

Zhenqi Zhou1, Vicent Ribas1, Prashant Rajbhandari2, Brian G Drew1, Timothy M Moore1, Amy H Fluitt1, Britany R Reddish1, Kate A Whitney1, Senta Georgia1, Laurent Vergnes3, Karen Reue3, Marc Liesa1, Orian Shirihai1, Alexander M van der Bliek4, Nai-Wen Chi5, Sushil K Mahata6, Joseph P Tiano7, Sylvia C Hewitt8, Peter Tontonoz2, Kenneth S Korach8, Franck Mauvais-Jarvis7, Andrea L Hevener9.   

Abstract

Estrogen receptor α (ERα) action plays an important role in pancreatic β-cell function and survival; thus, it is considered a potential therapeutic target for the treatment of type 2 diabetes in women. However, the mechanisms underlying the protective effects of ERα remain unclear. Because ERα regulates mitochondrial metabolism in other cell types, we hypothesized that ERα may act to preserve insulin secretion and promote β-cell survival by regulating mitochondrial-endoplasmic reticulum (EndoRetic) function. We tested this hypothesis using pancreatic islet-specific ERα knockout (PERαKO) mice and Min6 β-cells in culture with Esr1 knockdown (KD). We found that Esr1-KD promoted reactive oxygen species production that associated with reduced fission/fusion dynamics and impaired mitophagy. Electron microscopy showed mitochondrial enlargement and a pro-fusion phenotype. Mitochondrial cristae and endoplasmic reticulum were dilated in Esr1-KD compared with ERα replete Min6 β-cells. Increased expression of Oma1 and Chop was paralleled by increased oxygen consumption and apoptosis susceptibility in ERα-KD cells. In contrast, ERα overexpression and ligand activation reduced both Chop and Oma1 expression, likely by ERα binding to consensus estrogen-response element sites in the Oma1 and Chop promoters. Together, our findings suggest that ERα promotes β-cell survival and insulin secretion through maintenance of mitochondrial fission/fusion-mitophagy dynamics and EndoRetic function, in part by Oma1 and Chop repression.

Entities:  

Keywords:  apoptosis; endoplasmic reticulum stress (ER stress); estrogen action; estrogen receptor; insulin secretion; mitochondrial dynamics; mitochondrial metabolism

Mesh:

Substances:

Year:  2018        PMID: 29378845      PMCID: PMC5880140          DOI: 10.1074/jbc.M117.805069

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  59 in total

Review 1.  Minireview: Autophagy in pancreatic β-cells and its implication in diabetes.

Authors:  Hirotaka Watada; Yoshio Fujitani
Journal:  Mol Endocrinol       Date:  2015-01-29

2.  Activation of mitochondrial protease OMA1 by Bax and Bak promotes cytochrome c release during apoptosis.

Authors:  Xian Jiang; Hui Jiang; Zhirong Shen; Xiaodong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-01       Impact factor: 11.205

3.  β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.

Authors:  Philippe A Halban; Kenneth S Polonsky; Donald W Bowden; Meredith A Hawkins; Charlotte Ling; Kieren J Mather; Alvin C Powers; Christopher J Rhodes; Lori Sussel; Gordon C Weir
Journal:  J Clin Endocrinol Metab       Date:  2014-04-08       Impact factor: 5.958

4.  OPA1-dependent cristae modulation is essential for cellular adaptation to metabolic demand.

Authors:  David A Patten; Jacob Wong; Mireille Khacho; Vincent Soubannier; Ryan J Mailloux; Karine Pilon-Larose; Jason G MacLaurin; David S Park; Heidi M McBride; Laura Trinkle-Mulcahy; Mary-Ellen Harper; Marc Germain; Ruth S Slack
Journal:  EMBO J       Date:  2014-10-08       Impact factor: 11.598

5.  The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR.

Authors:  Dan Egan; Joungmok Kim; Reuben J Shaw; Kun-Liang Guan
Journal:  Autophagy       Date:  2011-06-01       Impact factor: 16.016

Review 6.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Nat Cell Biol       Date:  2011-09-02       Impact factor: 28.824

7.  Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

Authors:  Alka M Kanaya; David Herrington; Eric Vittinghoff; Feng Lin; Deborah Grady; Vera Bittner; Jane A Cauley; Elizabeth Barrett-Connor
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

Review 8.  The role of hypothalamic estrogen receptors in metabolic regulation.

Authors:  Aaron Frank; Lynda M Brown; Deborah J Clegg
Journal:  Front Neuroendocrinol       Date:  2014-05-29       Impact factor: 8.606

9.  YME1L controls the accumulation of respiratory chain subunits and is required for apoptotic resistance, cristae morphogenesis, and cell proliferation.

Authors:  Lukas Stiburek; Jana Cesnekova; Olga Kostkova; Daniela Fornuskova; Kamila Vinsova; Laszlo Wenchich; Josef Houstek; Jiri Zeman
Journal:  Mol Biol Cell       Date:  2012-01-19       Impact factor: 4.138

10.  Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance.

Authors:  Lin Zhu; William C Brown; Qing Cai; Andrée Krust; Pierre Chambon; Owen P McGuinness; John M Stafford
Journal:  Diabetes       Date:  2012-09-10       Impact factor: 9.461

View more
  25 in total

1.  Assessing the impact of cigarette smoking on β-cell function and risk for type 2 diabetes in a non-diabetic Chinese cohort.

Authors:  Cai Chen; Ya-Qin Tu; Ping Yang; Qi-Lin Yu; Shu Zhang; Fei Xiong; Cong-Yi Wang
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

2.  Catechol estrogens stimulate insulin secretion in pancreatic β-cells via activation of the transient receptor potential A1 (TRPA1) channel.

Authors:  Wenzhen Ma; Xingjuan Chen; Rok Cerne; Samreen K Syed; James V Ficorilli; Over Cabrera; Alexander G Obukhov; Alexander M Efanov
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

3.  Sex as a Biological Variable: A 5-Year Progress Report and Call to Action.

Authors:  Matthew E Arnegard; Lori A Whitten; Chyren Hunter; Janine Austin Clayton
Journal:  J Womens Health (Larchmt)       Date:  2020-01-22       Impact factor: 2.681

4.  Tamoxifen Improves Glucose Tolerance in a Delivery-, Sex-, and Strain-Dependent Manner in Mice.

Authors:  Alexis M Ceasrine; Nelmari Ruiz-Otero; Eugene E Lin; David N Lumelsky; Erica D Boehm; Rejji Kuruvilla
Journal:  Endocrinology       Date:  2019-04-01       Impact factor: 4.736

Review 5.  The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer.

Authors:  Joseph R Inigo; Dhyan Chandra
Journal:  J Hematol Oncol       Date:  2022-07-21       Impact factor: 23.168

Review 6.  Sex differences in autonomic responses to stress: implications for cardiometabolic physiology.

Authors:  Carley Dearing; Robert J Handa; Brent Myers
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-06       Impact factor: 5.900

7.  Transcriptomic and Quantitative Proteomic Profiling Reveals Signaling Pathways Critical for Pancreatic Islet Maturation.

Authors:  Yu-Chin Lien; Kyoung-Jae Won; Rebecca A Simmons
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

8.  Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-β-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons.

Authors:  Sara M Zarate; Gauri Pandey; Sunanda Chilukuri; Jose A Garcia; Brittany Cude; Shannon Storey; Nihal A Salem; Eric A Bancroft; Michelle Hook; Rahul Srinivasan
Journal:  J Neurochem       Date:  2021-01-10       Impact factor: 5.372

9.  Phenotypic sexual dimorphism in response to dietary fat manipulation in C57BL/6J mice.

Authors:  Isabel Casimiro; Natalie D Stull; Sarah A Tersey; Raghavendra G Mirmira
Journal:  J Diabetes Complications       Date:  2020-11-28       Impact factor: 2.852

Review 10.  Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases.

Authors:  Christoffer Clemmensen; Brian Finan; Timo D Müller; Richard D DiMarchi; Matthias H Tschöp; Susanna M Hofmann
Journal:  Nat Rev Endocrinol       Date:  2019-02       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.